On June 21 2018, Steve Shadowen will address the American Antitrust Institute during its 19th Annual Conference.
The conference's theme this year is “Antitrust at a Crossroads: Plotting the Policy Course for the Next Decade.”
Steve Shadowen will provide insight into topics concerning U.S. antitrust enforcement in the pharmaceutical industry, specifically focusing on recent legal developments concerning antitrust challenges to pay-for-delay patent settlements and product hopping.
Steve Shadowen serves as panelist alongside leading antitrust trial lawyers at the California Bar Association's Golden State Antitrust and Unfair Competition Law Institute & Antitrust Lawyer of the Year Reception and Dinner. The panelists discussed their recent trial experience in In re: Nexium (Esomeprazole Magnesium) Antitrust Litigation, the first pay for delay case to go to trial since the landmark decision of FTC v. Actavis, Inc.
Mr. Shadowen spoke at his alma mater, St. Edward University, during the school's Milestone Event, which united 130 students with 51 scholarship donors. Mr. Shadowen encouraged alumni and friends of the University to get involved in ensuring the survival of the College Assistance Migrant Program.
Steve Shadowen served as a panel member at an event put together by the American Bar Association's Section on Antitrust law, discussing how antitrust courts should address cases challenging product hopping practices.
The American Antitrust Institute elected Steve Shadowen to be one of its presenters at a symposium aimed at exploring the implications and applications of antitrust law in the wake of the landmark U.S. Supreme Court decision in FTC v. Actavis, Inc.